Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
China Journal of Chinese Materia Medica ; (24): 1449-1454, 2017.
Article Dans Chinois | WPRIM | ID: wpr-350164

Résumé

Pelvic inflammatory disease is an infectious disease. At present, Western medicine is mainly treated with antibiotics. However, the situation of antibiotics abuse is so grim that the potential risks such as the imbalance of bacteria, the resistance of bacteria, the production of super bacteria and the increase of adverse reactions are becoming more and more serious. Therefore, it is urgent to find a way to supplement or substitute antibiotics for the treatment of this disease. Traditional Chinese medicine treatment of the disease is effective and has its unique advantages. This paper mainly discusses the advantages and evidences of traditional Chinese medicine (TCM) treatment of pelvic inflammatory disease, to further prove the effectiveness and safety of TCM treatment and to provide medical evidence of reducing antibiotics use.

2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 920-924, 2005.
Article Dans Chinois | WPRIM | ID: wpr-269865

Résumé

<p><b>OBJECTIVE</b>To probe the effect of Zuogui pill (ZGP), a Chinese compound recipe for tonifying Shen, on ovarian function in mice with premature ovarian failure (POF).</p><p><b>METHODS</b>BALB/C female mice model of POF was established by multiple sites subcutaneous injection of ovarian antigen elicited with ovarian tissue of SD female rats, and treated with ZGP at different time points in the modeling, with prednisone as positive control. The levels of follicle-stimulating hormone (FSH) and estradiol (E2) in peripheral blood were measured with radioimmunoassay, and ovarian antibody (AoAb) was determined by enzyme linked immunosorbent assay. The mRNA expression of ovarian growth and differentiation factor-9 was detected with in situ hybridization.</p><p><b>RESULTS</b>POF model mice manifested such abnormalities as increased FSH, decreased E2, and positive AoAb in peripheral blood, with lymphocytes infiltration in ovarian mesanchyma, reduction of GDF-9 mRNA positive oocytes, and decrease of growing and mature follicles. ZGP could reduce the increase of FSH, increase the level of E2, inhibit the production of AoAb, raise the GDF-9 mRNA positive cells of oocytes, increase the number of growing and mature follicles. The clinical efficacy was more significant in early stage than in advanced stage.</p><p><b>CONCLUSION</b>ZGP can improve immune inflammatory injury of ovary, and shows therapeutic effect on POF.</p>


Sujets)
Animaux , Femelle , Souris , Rats , Maladies auto-immunes , Médicaments issus de plantes chinoises , Pharmacologie , Utilisations thérapeutiques , Médecine traditionnelle chinoise , Souris de lignée BALB C , Follicule ovarique , Anatomopathologie , Ovaire , Allergie et immunologie , Phytothérapie , Insuffisance ovarienne primitive , Répartition aléatoire , Rat Sprague-Dawley , Déficit du Yin , Traitement médicamenteux
SÉLECTION CITATIONS
Détails de la recherche